Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 10;39(15):2051-2066.
doi: 10.1002/sim.8529. Epub 2020 Apr 15.

A flexible nonlinear mixed effects model for HIV viral load rebound after treatment interruption

Affiliations

A flexible nonlinear mixed effects model for HIV viral load rebound after treatment interruption

Rui Wang et al. Stat Med. .

Abstract

Characterization of HIV viral rebound after the discontinuation of antiretroviral therapy is central to HIV cure research. We propose a parametric nonlinear mixed effects model for the viral rebound trajectory, which often has a rapid rise to a peak value followed by a decrease to a viral load set point. We choose a flexible functional form that captures the shapes of viral rebound trajectories and can also provide biological insights regarding the rebound process. Each parameter can incorporate a random effect to allow for variation in parameters across individuals. Key features of viral rebound trajectories such as viral set points are represented by the parameters in the model, which facilitates assessment of intervention effects and identification of important pretreatment interruption predictors for these features. We employ a stochastic expectation-maximization (StEM) algorithm to incorporate HIV-1 RNA values that are below the lower limit of assay quantification. We evaluate the performance of our model in simulation studies and apply the proposed model to longitudinal HIV-1 viral load data from five AIDS Clinical Trials Group treatment interruption studies.

Keywords: censoring; imputation; iterative; nonlinear; viral rebound.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Panel (a): Observed log10 viral load for 9 subjects. Panel (b): Schematic illustration of the curves represented by model (1)
FIGURE 2
FIGURE 2
Parameters values for 8000 iterations. Red lines indicate the parameter estimates, obtained by averaging over the last 2000 iterations. Green dashed-lines represents the 95% confidence interval calculated using model-based variance estimates.
FIGURE 3
FIGURE 3
Panel (a): Fitted reference curves including (solid line) and excluding “elite controllers" (dotted line). Panel (b): Individual fitted curves for 9 individuals. The blue dots represent observed viral load (log10-transformed) values over time. The red solid lines represent the fitted curves obtained from the proposed NLME model. The blue dotted lines represent the fitted curves obtained from the penalized spline model.

References

    1. Chun TW, Fauci AS. Latent reservoirs of HIV: obstacles to the eradication of virus. Proceedings of the National Academy of Sciences 1999; 96(20): 10958–10961. - PMC - PubMed
    1. Finzi D, Blankson J, Siliciano JD, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature medicine 1999; 5(5): 512. - PubMed
    1. Archin NM, Liberty A, Kashuba AD, et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 2012; 487(7408): 482. - PMC - PubMed
    1. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science 2009; 323(5919): 1304–1307. - PubMed
    1. Hurst J, Hoffmann M, Pace M, et al. Immunological biomarkers predict HIV-1 viral rebound after treatment interruption. Nature communications 2015; 6: 8495. - PMC - PubMed

Publication types

LinkOut - more resources